Children under 10 with drug-resistant TB often endure painful diagnostic procedures. MSF is pushing for non-invasive methods, such as stool GeneXpert, to alleviate this burden. Our Mumbai clinic has achieved a 75% treatment success rate using injectable-free regimens for eligible children. Join us in advocating for safer, oral options and eliminating the need for painful injectables. Your support is crucial for advancing better diagnostics and treatments for children with drug-resistant TB. Lear